*Human Pai 1 Recombinant Stable Mutant Lrp Binding Negative

Select this product for Molecular Innovations name, N-Terminal Cysteine Stable Mutant LRP Binding Mutant and product number, NTCYSCPAI-R76E.Human PAI-1 Recombinant Stable Mutant LRP Binding Negative from Innovative Research has been recombinantly produced in E. coli and purified by affinity chromatography. This is a Frozen liquid buffered in 0.05M Sodium Phosphate; 0.1M NaCl; 1mM EDTA; 1mM DTT; pH 6.6 and a purity of >95% as determined by SDS-PAGE. More Details: Species: Human Target: PAI-1 Purification Method: Affinity purified Purity: >95% as determined by SDS-PAGE Analysis Source: E. coli Storage Conditions: -70 C Additional Information: N-terminal cystein mutation along with four stabilization point mutations. Subsitution of Gultamic Acid for Argine at P76 decreases binding to low density lipoprotein recepter-related protein (LRP). Supplied in buffer with ImM DTT to prevent dimerization. This product can be used as a control in applications like ELISA and Western Blot. It can be used in a wide range of in vitro applications, including blocking/inhibition, fibrinolysis, plasminogen activation, receptor binding, in hypertension studies, for protein-protein interactions, and more. At Innovative Research, we provide reliable, consistent products that deliver reliable, consistent results.